GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (BOM:543654) » Definitions » EBITDA Margin %

Global Health (BOM:543654) EBITDA Margin % : 25.05% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Health EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Global Health's EBITDA for the three months ended in Mar. 2024 was ₹2,068 Mil. Global Health's Revenue for the three months ended in Mar. 2024 was ₹8,255 Mil. Therefore, Global Health's EBITDA margin for the quarter that ended in Mar. 2024 was 25.05%.


Global Health EBITDA Margin % Historical Data

The historical data trend for Global Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health EBITDA Margin % Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
15.53 15.59 22.60 24.99 26.68

Global Health Quarterly Data
Mar20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.63 25.79 27.68 28.11 25.05

Competitive Comparison of Global Health's EBITDA Margin %

For the Medical Care Facilities subindustry, Global Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Global Health's EBITDA Margin % falls into.



Global Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Global Health's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=8737.4/32751.11
=26.68 %

Global Health's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2067.702/8255.305
=25.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Health  (BOM:543654) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Global Health EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Global Health's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health (BOM:543654) Business Description

Traded in Other Exchanges
Address
E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (BOM:543654) Headlines

No Headlines